Recital 8, Directive (EU) 2001/83

In forcecited 1×

Standards and protocols for the performance of tests and trials on medicinal products are an effective means of control of these products and hence of protecting public health and can facilitate the movement of these products by laying down uniform rules applicable to tests and trials, the compilation of dossiers and the examination of applications.

  • Opinion of Advocate General Jääskinen delivered on 29 September 2011. European Commission v Republic of Poland.Decision

    More precisely, the aim of the marketing authorisation requirement in Article 6(1) of Directive 2001/83 is to guarantee that the potential risks of products are outweighed by their therapeutic efficacy, which is assessed on the basis of …

    29 Sep 2011 · 62010CC0185